IP Library Granted Patent US 10,066,043
Granted Patent B2
US 10,066,043 · App. 15/428,063 · Granted Sep 4, 2018

ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization

Inventors: Patrick S. Stayton (Seattle, WA); Allan S. Hoffman (Seattle, WA); Anthony J. Convertine (Seattle, WA); Scott M. Henry (Seattle, WA); Robert W. Overell (Shoreline, WA); Paul H. Johnson (Snohomish, WA)
Assignees: University of Washington; PhaseRx, Inc.
C08F293/005A61K47/48176A61K49/0054C08F2438/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,066,043
App. No.
15/428,063
Granted
Sep 4, 2018
Kind
B2
Abstract

Polymeric compounds having spatially controlled bioconjugation sites are described. Functionalization is achieved by selective ω-terminal chain extension of polymer chains by radical polymerization, such as reversible addition-fragmentation chain transfer (RAFT) polymerization.

Claims (32)

1. A method for preparing a polymer, the method comprising:

(a) providing a macromolecular chain transfer agent having a formula P n —Y, wherein P n is a first polymer chain, Y is a chain transfer residue having a formula SC(═S)Z, and Z is an activating group, and

(b) reacting a chain extension monomer and the macromolecular chain transfer agent under reversible addition-fragmentation chain transfer (RAFT) chain extension conditions to form a polymer having a formula P n -(E) k -Y, wherein k is an integer ranging from 1 to 20, and wherein chain extension residue E has a formula E3

wherein

R 1 and R 4 are each hydrogen,

R 2 , N—R 5 , and R 3 , together form an N-substituted imidyl moiety represented by the formula —C(O)NR 5 C(O)—, and

R 5 is a C 1 -C 20 moiety comprising (i) a functional group or (ii) a functional group covalently coupled to a biomolecular agent through a linking moiety, wherein the C 1 -C 20 moiety is selected from the group consisting of hydrocarbyl, substituted hydrocarbyl, hetero-hydrocarbyl, substituted hetero-hydrocarbyl, carbocyclic, substituted carbocyclic, heterocyclic, substituted heterocyclic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and fused-multiring structures comprising one or more of the foregoing, and wherein the functional group is selected from the group consisting of amino, ammonio, imino, amido, imidyl, nitrile, azo, azido, cyano, cyanato, isocyanato, isothiocyanto, hydrazide, nitro, nitroso, nitrosooxy, pyridyl, hydroxyl, alkoxy, carboxyl, ester, acyl, halo, haloformyl, phosphino, phosphoric, phospho, sulfide, disulfide, thio, thiol, sulfonyl, sulfo, sulfinyl, alkenyl, alkynl, allenyl, and silyl.

2. The method of claim 1 , further comprising

(c) reacting a set of one or more monomers and the polymer of formula P n -(E) k -Y under RAFT polymerization conditions to form a polymer having a formula P n -(E) k -P m —Y, wherein P m is a second polymer chain.

3. The method of claim 1 , further comprising preparing the macromolecular chain transfer agent of formula P n —Y before step (a).

4. The method of claim 3 , wherein preparing the macromolecular chain transfer agent comprises reacting a first set A of one or more monomers and a chain transfer agent comprising a thio-carbonyl-thio moiety under RAFT polymerization conditions.

5. The method of claim 4 , further comprising

(c) reacting a second set B of one or more monomers and the polymer of formula P n -(E) k -Y under RAFT polymerization conditions to form a polymer having a formula P n -(E) k -P m —Y, wherein P m is a second polymer chain.

6. The method of claim 5 , wherein the second set B of one or more monomers is different from the first set A of one or more monomers.

7. The method of claim 1 , further comprising cleaving the chain transfer residue Y to yield a chain transfer residue derivative, Y*.

8. The method of claim 7 , wherein Y* is selected from the group consisting of hydrogen and —SH.

9. The method of claim 1 , wherein k is an integer ranging from 1 to 10.

10. The method of claim 9 , wherein each of the macromolecular chain transfer agent and the polymer of formula P n -(E) k -Y has a polydispersity index, M w /M n , of less than 1.5, and wherein the polydispersity index of the polymer of formula P n -(E) k -Y differs from the polydispersity index of the macromolecular chain transfer agent by not more than 10%.

11. The method of claim 10 , wherein the polydispersity index of the polymer of formula P n -(E) k -Y differs from the polydispersity index of the macromolecular chain transfer agent by not more than 5%.

12. The method of claim 1 , wherein R 5 comprises (ii) the functional group covalently coupled to the biomolecular agent through the linking moiety.

13. The method of claim 12 , wherein the biomolecular agent is selected from the group consisting of a therapeutic agent and a targeting moiety.

14. The method of claim 12 , wherein the biomolecular agent is selected from the group consisting of a polynucleic acid, a polyamino acid, a polysaccharide, and a small molecule.

15. A method for preparing a polymer, the method comprising:

(a) providing a macromolecular chain transfer agent having a formula P n —Y, wherein P n is a first polymer chain, Y is a chain transfer residue having a formula SC(═S)Z, and Z is an activating group, and

(b) reacting a chain extension monomer and the macromolecular chain transfer agent under reversible addition-fragmentation chain transfer (RAFT) chain extension conditions to form a polymer having a formula P n -(E) k -Y, wherein k is an integer ranging from 1 to 20, and wherein chain extension residue E has a formula E3

wherein

R 1 and R 4 are each hydrogen,

R 2 , N-R 5 , and R 3 , together form an N-substituted imidyl moiety represented by the formula —C(O)NR 5 C(O)—, and

R 5 is a C 1 -C 20 moiety comprising a primary or secondary amine, wherein the C 1 -C 20 moiety is selected from the group consisting of hydrocarbyl, substituted hydrocarbyl, hetero-hydrocarbyl, substituted hetero-hydrocarbyl, carbocyclic, substituted carbocyclic, heterocyclic, substituted heterocyclic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and fused-multi-ring structures comprising one or more of the foregoing, and

(c) conjugating a biomolecular agent to the polymer of formula P n -(E) k -Y utilizing the primary or secondary amine.

16. The method of claim 15 , wherein the biomolecular agent is selected from the group consisting of a therapeutic agent and a targeting moiety.

17. The method of claim 15 , wherein the biomolecular agent is selected from the group consisting of a polynucleic acid, a polyamino acid, a polysaccharide, and a small molecule.

Assignments (6)
CONFIRMATORY LICENSE Recorded May 19, 2020
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052698/0522 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 3, 2020
From: GENEVANT SCIENCES LTD.
To: ROIVANT SCIENCES LTD.
Reel/Frame 052312/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2018
From: PHASERX, INC.
To: ROIVANT HEPATOLOGY GMBH
Reel/Frame 047649/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2018
From: ROIVANT HEPATOLOGY GMBH
To: GENEVANT SCIENCES GMBH
Reel/Frame 047689/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2018
From: OVERELL, ROBERT W.; JOHNSON, PAUL H.
To: PHASERX, INC.
Reel/Frame 046510/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2018
From: STAYTON, PATRICK S.; HOFFMAN, ALLAN S.; CONVERTINE, ANTHONY J.; HENRY, SCOTT M.
To: UNIVERSITY OF WASHINGTON
Reel/Frame 046510/0898 →
Continuity (3)
Continuation 13133355
Provisional Application 61120756 · Dec 8, 2008
Related Publication 20170145141A1 · May 25, 2017